Why All The Fuss About Ivermectin? Authored by Brian C. Joondeph via AmericanThinker.com, First hydroxychloroquine, now ivermectin, is the hated deadly drug de jour, castigated by the...
Amazon Tells Contractors To Stop Screening For Marijuana As Hiring Binge Begins Both Amazon and Walmart are about to make massive pushes to add more than 55,000...
The internationally recognised composer, peace worker and musical therapy pioneer tells pharmaphorum how his emerging field stands at The post Prof Nigel Osborne: Science is catching...
The COVID-19 pandemic and a growing global refugee crisis have shone a light on the ever-increasing need for new approaches to mental health treatment.
NICE has recommended broadening NHS use of Novartis’ IL-17 inhibitor Cosentyx to include children aged six to 17 The post NICE backs Cosentyx’ use in thousands...
Since Milton Friedman’s passing in 2006, his legacy has drawn considerable fire for all the usual reasons of political expediency and ideology. Both have come into...
TORONTO – Sunwing says as part of its enduring commitment to health and safety, the company has announced it is requiring that all new and existing...
Although stretched thin and imperfect, health care workers do our best for everyone who needs us, regardless of the personal choices people have made.
Janssen Pharmaceuticals, the wholly-owned subsidiary of Johnson & Johnson (JNJ), has bagged the U.S. Food and Drug Administration’s (FDA) approval for INVEGA HAFYERA, an injectable drug to treat...
Anna Biosciences’ Dr Anthony Rullo discusses the drug development company’s immunotherapy platform. Over the last 30 years, we The post Targeting COVID-19 and cancer with immunotherapy...
Shared in Mesoblast dropped on the last day of August 2021 after the Melbourne-based biotech was told that the company's investigational respiratory treatment for Covid-19 needed to...
Investors interested in the life science sector should know the top oncology companies. Here the Investing News Network highlights eight on the NASDAQ. The post 8...
This inquiry must meet high public expectations, demonstrate independence and provide answers to many technical and policy questions – all made more difficult because of past...
Merck & Co. and partner Ridgeback Biotherapeutics said on Wednesday they had begun enrolling patients in a late-stage trial of their experimental drug molnupiravir for the...
Pfizer Inc. started dosing in a mid-to-late-stage trial of the company's oral antiviral therapy for Covid-19 in non-hospitalized, symptomatic adult patients.
Tools for altering gene expression—CRISPRi, CRISPRa, CRISPRoff, and CRISPRon—and CRISPR-compatible cellular models are opening new research possibilities. The post CRISPR: New Techniques and Complex Models appeared...
Ohio Judge Orders Hospital To Treat Ventilated COVID-19 Patient With Ivermectin By Lil Hai of Epoch Times A healthcare professional prepares to enter a Covid-19 patient's...
The new Cancer Care in Europe: Recovering from COVID-19 Disruption white paper assesses the disruption to patient care and The post How pharma can help the post-COVID...
Johnson & Johnson’s HIV vaccine candidate has failed its first major efficacy test, as it was unable to The post J&J vaccine fails to protect women...
Check out these health care stocks making headlines as the world continues to deal with the coronavirus pandemic. The post Most Active Stocks Today? 5 Health...
Naturally Splendid Enterprises Ltd. (“Naturally Splendid“, “NSE” or “the Company”) (FSE:50N)(TSXV:NSP)(OTC PINK:NSPDF) announces its unaudited financial results for the six months ended June 30, 2021. All...
Penny stocks, you either love them or you hate them. One of the obvious draws of these stocks trading for under $5 per share is the...
A new study on Covid-19 behavior has found that patients affected by the virus might have died due to a buildup of coronavirus directly in the lungs and...
Johnson & Johnson announced that the company's Imbokodo Phase IIb trial in HIV failed to hit the primary endpoint. The study evaluated J&J’s investigational HIV vaccine...
In a survey released by oncology data leader COTA, half of the respondents pointed to “Operation Warp Speed” for the Covid-19 pandemic as the seed of their...
Some states have a legal framework allowing “mature minors” to make their own health care decisions – but they apply it in different ways, and some...
Belgium-based Bone Therapeutics' Phase III osteoarthritis study using the company's enhanced viscosupplement JTA-004 failed to meet primary and critical secondary endpoints.
These penny stocks could be in focus as we turn the page on a new month. The post 5 Penny Stocks To Watch For September With...
A universal vaccine has been described as the ‘holy grail’ – but how close are we to getting one?
Just a few hours after Sanofi and Regeneron unveiled a new slate of data for Dupixent in children with eczema, Pfizer released its own results for...